Browsing: Second

This is a paid press release. Contact the press release distributor directly with any inquiries.

This is a paid press release. Contact the press release distributor directly with any inquiries.

Second quarter 2026 net product revenue of $18.6 million; cash and cash equivalents of $219.1 million as of June 30, 2026

Cash generation remains strong with Adjusted Free Cash Flow conversion higher year-on-year

This is a paid press release. Contact the press release distributor directly with any inquiries.

This is a paid press release. Contact the press release distributor directly with any inquiries.

This is a paid press release. Contact the press release distributor directly with any inquiries.

This is a paid press release. Contact the press release distributor directly with any inquiries.

This is a paid press release. Contact the press release distributor directly with any enquiries.

NEPHRO CRRT clinical study of nafamostat is 75% enrolled; expected to be complete this year